几种常见的细小病毒病毒样颗粒研究进展
摘要
<正>致病性细小病毒大多为单股DNA病毒[1],分类地位主要集中在细小病毒科,按国际病毒分类委员会(ICTV)编写的分类报告,根据各种细小病毒侵染的宿主不同,可将细小病毒科分为两个亚科,分别是侵染脊椎动物的细小病毒亚科(Parvovirinae)和侵染昆虫等节肢动物的浓核病毒亚科(Densovirinae)[2]。近年来流行较为严重的犬、猪和鹅等细小病毒均具有很强的破坏力,传统疫苗的控制较为有限,加大新型疫苗的研制刻不容缓。病毒样颗粒(V
引文
[1] Zadori Z,Erdei J,Nagy J,et al.Characteristics of the genome of goose parvovirus[J].Avian Pathology,1994,23(2):359- 364.
[2] Brown K E,Green S W,Young N S.Goose parvovirus—an autonomous member of the dependovirus genus?[J].Virology,1995,210(2):283- 291.
[3] Zeltins A.Construction and characterization of virus-like particles:a review[J].Molecular biotechnology,2013,53(1):92- 107.
[4] 杜毅超,吴健敏,刘金凤.猪细小病毒病毒样颗粒研究进展[J].动物医学进展,2016,37(07):71- 75.
[5] 罗尚星,申小强,顾文源,等.影响猪树突状细胞对猪细小病毒样颗粒提呈方式的因素[J].畜牧兽医学报,2017,48(3):508- 514.
[6] 王斌,徐绮嫔,郭慧琛,等.犬细小病毒病毒样颗粒研究进展[J].动物医学进展,2016,37(3):81- 85.
[7] 陈进会,刘国庆,颜其贵,等.犬细小病毒病毒样颗粒的研究进展[J].检验检疫学刊,2016,26(4):69- 72.
[8] Feng H,Hu G,Wang H,et al.Canine parvovirus VP2 protein expressed in silkworm pupae self-assembles into virus-like particles with high immunogenicity[J].PloS one,2014,9(1):e79575.
[9] Xu J,Guo H C,Wei Y Q,et al.Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine[J].Applied microbiology and biotechnology,2014,98(8):3 529- 3 538.
[10] 王斌.犬细小病毒病毒样颗粒包被量子点复合物的构建和性质分析[D].成都:四川农业大学,2015.
[11] 朱玲,郭万柱,蒋清蓉,等.猪细小病毒VLPs供外源蛋白插入的候选位点发现及其重组PCV2-ORF2的病毒样颗粒构建[J].农业生物技术学报,2010,18(3):431- 436.
[12] 邸晶美,左玉柱,申小强,等.不同药物对树突状细胞捕获猪细小病毒样颗粒的影响[J].中国兽医学报,2016,36(7):1 157- 1 162.
[13] Burneikiene R P,Tamosiunas P L,Akatov A,et al.Generation of recombinant porcine parvovirus virus-like particles in Saccharomyces cerevisiae and development of virus-specific monoclonal antibodies[J].Journal of Biotechnology,2014 (185):S39.
[14] Antonis A F G,Bruschke C J M,Rueda P,et al.A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure[J].Vaccine,2006,24(26):5 481- 5 490.
[15] 陈杨,郭万柱,陈弟诗.猪细小病毒VP2蛋白病毒样颗粒在伪狂犬病病毒表达系统中的表达[J].中国兽医学报,2011,31(10):1 385- 1 389.
[16] 邹小辉,董流昕,宋敬东,等.人细小病毒B19病毒样颗粒的制备[J].生物工程学报,2009,25(4):575- 579.
[17] Sánchez-Rodríguez S P,Münch-Anguiano L,Echeverría O,et al.Human parvovirus B19 virus-like particles:In vitro assembly and stability[J].Biochimie,2012,94(3):870- 878.
[18] Sánchez-Rodríguez S P,Enrriquez-Avila J V,Soto-Fajardo J M,et al.In vitro encapsulation of heterologous dsDNA into human parvovirus B19 virus-like particles[J].Molecular biotechnology,2015,57(4):309- 317.
[19] Ju H,Wei N,Wang Q,et al.Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose[J].Biochemical and biophysical research communications,2011,409(1):131- 136.
[20] Chen Z,Li C,Zhu Y,et al.Immunogenicity of virus-like particles containing modified goose parvovirus VP2 protein[J].Virus research,2012,169(1):306- 309.
[2] Brown K E,Green S W,Young N S.Goose parvovirus—an autonomous member of the dependovirus genus?[J].Virology,1995,210(2):283- 291.
[3] Zeltins A.Construction and characterization of virus-like particles:a review[J].Molecular biotechnology,2013,53(1):92- 107.
[4] 杜毅超,吴健敏,刘金凤.猪细小病毒病毒样颗粒研究进展[J].动物医学进展,2016,37(07):71- 75.
[5] 罗尚星,申小强,顾文源,等.影响猪树突状细胞对猪细小病毒样颗粒提呈方式的因素[J].畜牧兽医学报,2017,48(3):508- 514.
[6] 王斌,徐绮嫔,郭慧琛,等.犬细小病毒病毒样颗粒研究进展[J].动物医学进展,2016,37(3):81- 85.
[7] 陈进会,刘国庆,颜其贵,等.犬细小病毒病毒样颗粒的研究进展[J].检验检疫学刊,2016,26(4):69- 72.
[8] Feng H,Hu G,Wang H,et al.Canine parvovirus VP2 protein expressed in silkworm pupae self-assembles into virus-like particles with high immunogenicity[J].PloS one,2014,9(1):e79575.
[9] Xu J,Guo H C,Wei Y Q,et al.Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine[J].Applied microbiology and biotechnology,2014,98(8):3 529- 3 538.
[10] 王斌.犬细小病毒病毒样颗粒包被量子点复合物的构建和性质分析[D].成都:四川农业大学,2015.
[11] 朱玲,郭万柱,蒋清蓉,等.猪细小病毒VLPs供外源蛋白插入的候选位点发现及其重组PCV2-ORF2的病毒样颗粒构建[J].农业生物技术学报,2010,18(3):431- 436.
[12] 邸晶美,左玉柱,申小强,等.不同药物对树突状细胞捕获猪细小病毒样颗粒的影响[J].中国兽医学报,2016,36(7):1 157- 1 162.
[13] Burneikiene R P,Tamosiunas P L,Akatov A,et al.Generation of recombinant porcine parvovirus virus-like particles in Saccharomyces cerevisiae and development of virus-specific monoclonal antibodies[J].Journal of Biotechnology,2014 (185):S39.
[14] Antonis A F G,Bruschke C J M,Rueda P,et al.A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure[J].Vaccine,2006,24(26):5 481- 5 490.
[15] 陈杨,郭万柱,陈弟诗.猪细小病毒VP2蛋白病毒样颗粒在伪狂犬病病毒表达系统中的表达[J].中国兽医学报,2011,31(10):1 385- 1 389.
[16] 邹小辉,董流昕,宋敬东,等.人细小病毒B19病毒样颗粒的制备[J].生物工程学报,2009,25(4):575- 579.
[17] Sánchez-Rodríguez S P,Münch-Anguiano L,Echeverría O,et al.Human parvovirus B19 virus-like particles:In vitro assembly and stability[J].Biochimie,2012,94(3):870- 878.
[18] Sánchez-Rodríguez S P,Enrriquez-Avila J V,Soto-Fajardo J M,et al.In vitro encapsulation of heterologous dsDNA into human parvovirus B19 virus-like particles[J].Molecular biotechnology,2015,57(4):309- 317.
[19] Ju H,Wei N,Wang Q,et al.Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose[J].Biochemical and biophysical research communications,2011,409(1):131- 136.
[20] Chen Z,Li C,Zhu Y,et al.Immunogenicity of virus-like particles containing modified goose parvovirus VP2 protein[J].Virus research,2012,169(1):306- 309.